Tausha Flux has extensive experience in regulatory affairs and clinical research, currently serving as a Study Start-Up Specialist II and Site File Specialist II at IQVIA since February 2019, following its acquisition of Novella Clinical where Tausha worked as a Site File Specialist I. Previous roles include Regulatory Specialist I at Moffitt Cancer Center, where responsibilities involved ensuring compliance with FDA regulations and supporting research committees. Tausha also held director-level positions for regulatory affairs at Meridian Clinical Research and Tampa Bay Medical Research, overseeing regulatory submission initiatives and staff training. Early career experience includes roles in quality control, remote data entry, and laboratory management, providing a strong foundation in clinical research operations.